Edgar Engleman, Director at Bolt Biotherapeutics, Inc. (BOLT), sold 1,943 shares at $0.90 ($2K) on 2023-11-21, disclosed to the SEC on 2023-11-22.
Open-market sale of $2k BOLT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.90 | 236 | $212 | 12.1% |
| 2 | $0.90 | 1,707 | $2K | 87.9% |
| Total | $0.90 avg | 1,943 | $2K | 100% |
| Filing → |
| BOLT | BUY | 2021-02-09 | $4.0M | — | Filing → |
| BOLT | SELL | 2021-02-09 | $3K | — | Filing → |
| SLNO | BUY | 2017-12-19 | $4.0M | — | Filing → |